Plant-based vaccines against human hepatitis B virus

Expert Review of Vaccines

Volumn 9, Issue 8, 2010, Pages 947-955

  Shchelkunov, Sergei N ^a   Shchelkunova, Galina A ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

edible vaccine; hepatitis B virus; plant virus; protective antigen; transgenic plant; vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT VACCINE;

HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAMMAL CELL; NONHUMAN; PLANT; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRANSGENIC PLANT; VACCINE PRODUCTION; VIRUS GENOME; VIRUS REPLICATION; YEAST; BIOSYNTHESIS; BIOTECHNOLOGY; GENETICS; METABOLISM; MUCOSAL IMMUNITY; PHARMACEUTICS; PROCEDURES;

BIOTECHNOLOGY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNITY, MUCOSAL; PLANTS, GENETICALLY MODIFIED; TECHNOLOGY, PHARMACEUTICAL; VACCINES, SYNTHETIC;

EID: 77955263748     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.67     Document Type: Review

References (49)

1. Ganem D, Prince AM. Hepatitis B virus infection- natural history and clinical consequences. N. Engl. J. Med. 350 (11), 1118-1129 (2004).
2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol. 14 (27), 4300-4308 (2008).
3. Kumar GB, Ganapathi TR, Bapat VA. Production of hepatitis B surface antigen in recombinant plant systems: an update. Biotechnol. Prog. 23(3), 532-539 (2007).
4. Clements CJ, Coghlan B, Creati M et al. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull. World Health Organ. 88, 66-73 (2010).
5. Block TM, Guo H, Guo J-T. Molecular virology of hepatitis B virus for clinicians. Clin. LiverDis. 11, 685-706 (2007).
6. Beck J, Nassal M. Hepatitis B virus replication. World J. Gastroenterol. 13, 48-64 (2007).
7. Patient R, Hourioux C, Roingeard P. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol. 11, 1561-1570 (2009).
8. Emini EA, Ellis RW, Miller WJ, McAller WJ, Scolnik EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccine. J. Infect. 13(Suppl. A), 3-9 (1986).
9. Banatvala JE, Van Damme P. Hepatitis B vaccine - do we need boosters? J. Viral Hepatitis 10, 1-6 (2003).
10. Youm JW, Won YS, Jeon JH et al. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice. Vaccine 25, 577-584 (2007).
11. Streatfield SJ. Oral hepatitis B vaccine candidates produced and delivered in plant material. Immunol. Cell Biol. 83(3), 257-262 (2005).
12. Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6, 148-158 (2006).
13. Shchelkunova GA, Shchelkunov SN. Edible vaccines on the basis of trasgenic plants. Mol. Med. 2, 3-12 (2008).
14. Streatfield SJ, Jilka JM, Hood EE et al. Plant-based vaccines: unique advantages. Vaccine 19, 2742-2748 (2001).
15. Daniell H, Streatfield SJ, Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant. Sci. 6, 219-226 (2001).
16. Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA 89, 11745-11749 (1992).
17. Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl Acad. Sci. USA 92, 3358-3361 (1995).
18. Kostrzak A, Cervantes Gonzalez M, Guetard D et al. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine 27, 4798-4807 (2009).
19. Kapusta J, Modelska A, Figlerowicz M et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796-1799 (1999).
20. Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl Acad. Sci. USA 98, 11539-11544 (2001).
21. Thanavala Y, Mahoney M, Pal S et al. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl Acad. Sci. USA 102, 3378-3382 (2005).
22. Gao Y, Ma Y, Li M et al. Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. World J. Gastroenterol. 9 (5), 996-1002 (2003).
23. Itoh Y, Takai E, Ohnuma H et al. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc. Natl Acad. Sci. USA 83, 9174-9178 (1986).
24. Park SS, Ryu CJ, Gripon P, Guguen-Guillouzo C, Hong HJ. Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus. Hybridoma 15(6), 435-1341 (1996).
25. Neurath AR, Seto B, Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (Env) protein are virus-neutralizing and protective. Vaccine 7, 234-236 (1989).
26. Joung YH, Youm JW, Jeon JH et al. Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum. Plant Cell Rep. 22, 925-930 (2004).
27. Lou X-M, Yao Q-H, Zhang Z et al. Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants. Clin. Vaccine Immunol. 14(4), 464-469 (2007).
28. Rendi-Wagner P, Shouval D, Genton B et al. Comparative immunogenicity of a preS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine 24, 2781-2789 (2006).
29. Raz R, Dagan R, Gallil A, Brill G, Kassis I, Koren R. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in children. Vaccine 14, 207-211 (1996).
30. Shchelkunov SN, Nesterov AE, Pozdnyakov SG et al. Comparative analysis of oral immunogenicity of the transgenic carrot variants producing hepatitis B virus S or M antigens. Rus. Immunol. J. 3(12), 235-245 (2009).
31. Fudjisawa Y, Itoh Y, Asano T. Studies on a new type of yeast-derived hepatitis B vaccine (a third generation vaccine). J. Takeda Res. Lab. 48, 21-32 (1989).
32. Qian B, Shen H, Liang W et al. Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds. Transgenic Res. 17(4), 621-631 (2008).
33. Greco R, Michel M, Guetard D et al. Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine 25, 8228-8240 (2007).
34. Shchelkunov SN, Salyaev RK, Rekoslavskaya NI et al. The obtaining of transgenic tomato plant producing chimerical proteins TBI-HBsAg. Dokl. Biochem. Biophys. 396, 139-142 (2004).
35. Shchelkunov SN, Salyaev RK, Ryzhova TV et al. Designing of a candidate edible vaccine against hepatitis B and HIV on the basis of a transgenic tomato. Vestn. Ross. Akad. Med. Nauk 11, 50-55 (2004).
36. Shchelkunov SN, Salyaev RK, Rekoslavskaya NI et al. Study of immunogenic properties of the candidate edible vaccine against human immunodeficiency and hepatitis B viruses based on transgenic tomato fruits. Dokl. Biochem. Biophys. 401, 167-169 (2005).
37. Shchelkunov SN, Salyaev RK, Pozdnyakov SG et al. Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol. Lett. 28(13), 959-967 (2006).
38. Pickering RJ, Smith SD, Strugnell RA et al. Crude saponins improve the immune response to an oral plant-made measles vaccine. Vaccine 24, 144-150 (2006).
39. Morrow WJW, Yang YW, Sheikh NA. Immunobiology of the tomatine adjuvant. Vaccine 22, 2380-2384 (2004).
40. Huang Z, LePore K, Elkin G, Thanavala Y, Mason HS. High-yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system. Plant Biotechnol. J. 6, 202-209 (2008).
41. Guetard D, Greco R, Cervantes Gonzalez M et al. Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration. Vaccine 26, 4477-4485 (2008).
42. Richer LJ, Thanavala Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18, 1167-1171 (2000).
43. Sojikul P, Buehner N, Masson HS. A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc. Natl Acad. Sci. USA 100, 2209-2214 (2003)
44. Yoshida K, Matsui T, Shinmyo A. The plant vesicular transport engineering for production of useful recombinant proteins. J. Mol. Catalysis B: Enzymatic 28, 167-171 (2004)
45. Deineko EV, Zagorskaya AA, Pozdnyakov SG et al. Comparative analysis of HBV M-antigen production in leaves of individual transgenic carrot plants. Dokl. Biochem. Biophys. 425, 76-79 (2009).
46. Bock R, Khan MS. Taming plastids for a green future. Trends Biotechnol. 22, 311-318 (2004).
47. Daniell H, Chebolu S, Kumar S, Singleton M, Falconer R. Chloroplast- derived vaccine antigens and other therapeutic proteins. Vaccine 23, 1779-1783 (2005).
48. Ruf S, Hermann M, Berger IJ, Carrer H, Bock R. Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nat. Biotechnol. 19, 870-875 (2001).
49. Tiwari S, Verma PC, Singh PK, Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol. Adv. 27 (4), 449-467 (2009).